Ligand · CT6
CT6 · (5Z)-5-(3-bromocyclohexa-2,5-dien-1-ylidene)-N-(pyridin-4-ylmethyl)-1,5-dihydropyrazolo[1,5-a]pyrimidin-7-amine
CT6, (5Z)-5-(3-bromocyclohexa-2,5-dien-1-ylidene)-N-(pyridin-4-ylmethyl)-1,5-dihydropyrazolo[1,5-a]pyrimidin-7-amine (C18 H14 Br N5, 380.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- CT6
- Formula
- C18 H14 Br N5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
CT6 in 2 structures; the first of them:
- 2C68 · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · CT6 A1297 · binds GLU8, ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33 and 14 more
- 2C68 · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · CT6 A1297 · binds GLU8, ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33 and 14 more
Residues it binds most
GLU 2, ALA 2, ASP 2, GLN 2, GLY 2, LEU 2, LYS 2, PHE 2, VAL 2, ASN 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.